Vior Inc (VIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Vior Inc (VIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDNE74246FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Nuclear Energy
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vior Inc (Vior) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold and silver metal properties in North and Latin America. Its projects comprise Mosseau Gold project, Foothills Rutile project, Vezza-Noyard Gold project, Big Island Lake property, Domergue project, and Ligneris project. Vior’s Mosseau Gold project is located near the town of Lebel-Sur-Quevillon in the Abitibi Region of Quebec. The company’s Foothills Rutile project is located within the municipality of St-Urbain, east of Quebec City and includes two claim blocks map-designated claims covering an area. Its Ligneris project is located in north of the Bousquet Mine Complex and northeast of the city of Rouyn-Noranda. The company has its operations across Canada. Vior is headquartered in Quebec City, Canada.

Vior Inc Key Recent Developments

Mar 11,2021: Vior confirms several new prospective gold areas at Skyfall along a 37 km strike length of the Eastern Urban-Barry Belt, Abitibi, Quebec
Dec 23,2020: Societe d’Exploration Miniere Vior changes name to “Vior”
Dec 02,2020: Vior completes till sampling and expands its land position at Skyfall, Abitibi, Quebec
Sep 02,2020: Vior Appoints VP Corporate Development and New Board Member QUEBEC, CANADA, September 2, 2020 – SOCIÉTÉ D’EXPLORATION MINIÈRE VIOR INC. (“Vior”or the “Corporation”), (TSX-V: VIO, FRANKFURT: VL51) – is pleased to announce that Mr. Laurent Eustache is joini

This comprehensive SWOT profile of Vior Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vior Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Vior Inc – Key Information
Vior Inc – Overview
Vior Inc – Key Employees
Vior Inc – Key Employee Biographies
Vior Inc – Key Operational Heads
Vior Inc – Major Products and Services
Vior Inc – History
Vior Inc – Company Statement
Vior Inc – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Vior Inc – Business Description
Vior Inc – Corporate Strategy
Vior Inc – SWOT Analysis
SWOT Analysis – Overview
Vior Inc – Strengths
Vior Inc – Weaknesses
Vior Inc – Opportunities
Vior Inc – Threats
Vior Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Vior Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Vior Inc, Key Information
Vior Inc, Key Ratios
Vior Inc, Share Data
Vior Inc, Major Products and Services
Vior Inc, History
Vior Inc, Key Employees
Vior Inc, Key Employee Biographies
Vior Inc, Key Operational Heads
Vior Inc, Other Locations
Vior Inc, Subsidiaries

Vior Inc, Key Competitors
Vior Inc, SWOT Analysis
Vior Inc, Ratios based on current share price
Vior Inc, Annual Ratios
Vior Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Vior Inc (VIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nippon Telegraph and Telephone Corp (9432):企業の財務・戦略的SWOT分析
    Nippon Telegraph and Telephone Corp (9432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • John Lewis Partnership Plc:企業の戦略・SWOT・財務情報
    John Lewis Partnership Plc - Strategy, SWOT and Corporate Finance Report Summary John Lewis Partnership Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Koninklijke KPN NV (KPN):企業の財務・戦略的SWOT分析
    Koninklijke KPN NV (KPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Syneos Health Inc:企業の戦略・SWOT・財務分析
    Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hero AG:企業の戦略・SWOT・財務情報
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Lonza Group Ltd (LONN)-製薬・医療分野:企業M&A・提携分析
    Summary Lonza Group Ltd (Lonza) is a biopharmaceutical company that manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company offers active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers, vitamin B co …
  • AB Electrolux:企業の戦略・SWOT・財務情報
    AB Electrolux - Strategy, SWOT and Corporate Finance Report Summary AB Electrolux - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Oregon Health & Science University-製薬・医療分野:企業M&A・提携分析
    Summary Oregon Health & Science University (OHSU), a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center’s educational institute offers undergraduate and graduate courses in anesthesiology, derm …
  • Baloise Holding Ltd:企業の戦略・SWOT・財務情報
    Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tallgrass Energy Partners LP (TEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tallgrass Energy Partners LP (Tallgrass Energy), a midstream oil and gas company.. It offers natural gas transportation and storage services to customers in the Rocky Mountains and Midwest regions of the US. The company also provides crude oil transportation to customers in Wyoming, Colorado …
  • Dermalogica, Inc.:企業の戦略・SWOT・財務情報
    Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) is a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, oil well …
  • Adventist Health System:企業の戦略的SWOT分析
    Adventist Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Bakrieland Development Tbk:企業の戦略・SWOT・財務情報
    PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Santen Pharmaceutical Co Ltd (4536):製薬・医療:M&Aディール及び事業提携情報
    Summary Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC …
  • BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Crinetics Pharmaceuticals Inc (CRNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crinetics Pharmaceuticals Inc (Crinetics) is a developer of novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related cancers. The company’s products include neuropeptides and their receptors, orally-available somatostatin agon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆